Okyo Pharma (OKYO)

Last close As at 30/05/2025

USD1.84

−0.01 (−0.54%)

Market capitalisation

USD63m

Okyo Pharma is a clinical-stage biopharmaceutical company developing therapeutic compounds to treat ocular indications including dry eye disease and neuropathic corneal pain.

Latest Insights

Healthcare | Non client QV

Okyo Pharma — Targeting underserved corneal diseases

Sector

Healthcare

Equity Analyst

Jyoti Prakash

Jyoti Prakash, CFA

Director, healthcare

Key Management

  • Gary Jacob, PhD

    CEO

  • Keeren Shah

    CFO

Thematics

thematic

Healthcare

Healthcare-focused trusts: A sector on the mend

thematic

Healthcare

Deutsches Eigenkapitalforum (EKF) 2023 healthcare

volition01

thematic

Healthcare

VolitionRx – Decoding the DNA of cancer 

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free